Hyperthermochemotherapeutic in vivo isolated perfusion of the rat liver
This report describes a system of in vivo isolated perfusion of the rat liver. The effects of perfusion with 5‐fluorouracil (5‐FU) (0.125–1.5 g/kg) on survival, liver function, and hepatic regeneration are studied. A dose of 0.125–0.25 g/kg of 5‐FU produced acceptable toxicity with 0% and 25% mortal...
Gespeichert in:
Veröffentlicht in: | Cancer 1983-04, Vol.51 (7), p.1254-1260 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 1260 |
---|---|
container_issue | 7 |
container_start_page | 1254 |
container_title | Cancer |
container_volume | 51 |
creator | Miyazaki, Masaru Makowka, Leonard Falk, Rudolf E. Falk, William Venturi, David Ambus, Ulo Falk, Judith A. |
description | This report describes a system of in vivo isolated perfusion of the rat liver. The effects of perfusion with 5‐fluorouracil (5‐FU) (0.125–1.5 g/kg) on survival, liver function, and hepatic regeneration are studied. A dose of 0.125–0.25 g/kg of 5‐FU produced acceptable toxicity with 0% and 25% mortality rate, but induced liver dysfunction indicated by abnormal biochemical values and severe inhibition of hepatic regeneration. Doses of 0.5 g/kg, 1.0 g/kg, and 1.5 g/kg produced a mortality of 60%, 100%, and 100%, respectively. Regional hyperthermia (37–43°C) achieved by perfusion of the liver with heated saline produced an adverse effect on survival, liver function and hepatic regeneration, which are both temperature‐ and perfusion time‐dependent. Hyperthermochemotherapy using in vivo isolated hepatic perfusion might be acceptable for the treatment of unresectable liver cancer, but should not be utilized as an adjuvant therapy prior to hepatic resection without the use of hepatic growth factors which could reverse the inhibitory effect of hepatic perfusion. |
doi_str_mv | 10.1002/1097-0142(19830401)51:7<1254::AID-CNCR2820510714>3.0.CO;2-0 |
format | Article |
fullrecord | <record><control><sourceid>wiley_pubme</sourceid><recordid>TN_cdi_pubmed_primary_6825049</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>CNCR2820510714</sourcerecordid><originalsourceid>FETCH-LOGICAL-p2164-fe76be3e56cb6b970b4b4e0b2d62ddb72bb7fd3695510e38e70f462a4bb545fb3</originalsourceid><addsrcrecordid>eNpVkN1Kw0AQhRdRaq0-grCXepE6-59UEUrUtlAsiIJ3S7bZpStJE5K00rc3obXQqzPDOTNwPoRiAkMCQB8IRCoAwukdiUIGHMi9ICP1RKjgo9F49hLE7_EHDSkIAorwZzaEYbx4pAGcof7x-hz1ASAMBGffl-iqrn_aVVHBeqgnQyqAR300me5KWzUrW-XFcmXzohuT0m4av8R-jbd-W2BfF1nS2BS3UbepfbHGhcNtEldJgzO_tdU1unBJVtubgw7Q19vrZzwN5ovJLB7Pg5ISyQNnlTSWWSGXRppIgeGGWzA0lTRNjaLGKJcyGYm2mmWhVeC4pAk3RnDhDBug2_3fcmNym-qy8nlS7fShUOu7vf_rM7s72gR0h1Z3cHQHR_-j1YJopTu0uiWrT8lqpkHHC007OXHYH03Zc-I</addsrcrecordid><sourcetype>Index Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Hyperthermochemotherapeutic in vivo isolated perfusion of the rat liver</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><creator>Miyazaki, Masaru ; Makowka, Leonard ; Falk, Rudolf E. ; Falk, William ; Venturi, David ; Ambus, Ulo ; Falk, Judith A.</creator><creatorcontrib>Miyazaki, Masaru ; Makowka, Leonard ; Falk, Rudolf E. ; Falk, William ; Venturi, David ; Ambus, Ulo ; Falk, Judith A.</creatorcontrib><description>This report describes a system of in vivo isolated perfusion of the rat liver. The effects of perfusion with 5‐fluorouracil (5‐FU) (0.125–1.5 g/kg) on survival, liver function, and hepatic regeneration are studied. A dose of 0.125–0.25 g/kg of 5‐FU produced acceptable toxicity with 0% and 25% mortality rate, but induced liver dysfunction indicated by abnormal biochemical values and severe inhibition of hepatic regeneration. Doses of 0.5 g/kg, 1.0 g/kg, and 1.5 g/kg produced a mortality of 60%, 100%, and 100%, respectively. Regional hyperthermia (37–43°C) achieved by perfusion of the liver with heated saline produced an adverse effect on survival, liver function and hepatic regeneration, which are both temperature‐ and perfusion time‐dependent. Hyperthermochemotherapy using in vivo isolated hepatic perfusion might be acceptable for the treatment of unresectable liver cancer, but should not be utilized as an adjuvant therapy prior to hepatic resection without the use of hepatic growth factors which could reverse the inhibitory effect of hepatic perfusion.</description><identifier>ISSN: 0008-543X</identifier><identifier>EISSN: 1097-0142</identifier><identifier>DOI: 10.1002/1097-0142(19830401)51:7<1254::AID-CNCR2820510714>3.0.CO;2-0</identifier><identifier>PMID: 6825049</identifier><language>eng</language><publisher>New York: Wiley Subscription Services, Inc., A Wiley Company</publisher><subject>Alanine Transaminase - blood ; Alkaline Phosphatase - blood ; Animals ; Aspartate Aminotransferases - blood ; Bilirubin - blood ; Chemotherapy, Cancer, Regional Perfusion - adverse effects ; Chemotherapy, Cancer, Regional Perfusion - methods ; DNA - biosynthesis ; Fluorouracil - administration & dosage ; Fluorouracil - toxicity ; Hot Temperature - therapeutic use ; Liver - drug effects ; Liver - pathology ; Male ; Rats ; Sodium Chloride - adverse effects ; Time Factors</subject><ispartof>Cancer, 1983-04, Vol.51 (7), p.1254-1260</ispartof><rights>Copyright © 1983 American Cancer Society</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/6825049$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Miyazaki, Masaru</creatorcontrib><creatorcontrib>Makowka, Leonard</creatorcontrib><creatorcontrib>Falk, Rudolf E.</creatorcontrib><creatorcontrib>Falk, William</creatorcontrib><creatorcontrib>Venturi, David</creatorcontrib><creatorcontrib>Ambus, Ulo</creatorcontrib><creatorcontrib>Falk, Judith A.</creatorcontrib><title>Hyperthermochemotherapeutic in vivo isolated perfusion of the rat liver</title><title>Cancer</title><addtitle>Cancer</addtitle><description>This report describes a system of in vivo isolated perfusion of the rat liver. The effects of perfusion with 5‐fluorouracil (5‐FU) (0.125–1.5 g/kg) on survival, liver function, and hepatic regeneration are studied. A dose of 0.125–0.25 g/kg of 5‐FU produced acceptable toxicity with 0% and 25% mortality rate, but induced liver dysfunction indicated by abnormal biochemical values and severe inhibition of hepatic regeneration. Doses of 0.5 g/kg, 1.0 g/kg, and 1.5 g/kg produced a mortality of 60%, 100%, and 100%, respectively. Regional hyperthermia (37–43°C) achieved by perfusion of the liver with heated saline produced an adverse effect on survival, liver function and hepatic regeneration, which are both temperature‐ and perfusion time‐dependent. Hyperthermochemotherapy using in vivo isolated hepatic perfusion might be acceptable for the treatment of unresectable liver cancer, but should not be utilized as an adjuvant therapy prior to hepatic resection without the use of hepatic growth factors which could reverse the inhibitory effect of hepatic perfusion.</description><subject>Alanine Transaminase - blood</subject><subject>Alkaline Phosphatase - blood</subject><subject>Animals</subject><subject>Aspartate Aminotransferases - blood</subject><subject>Bilirubin - blood</subject><subject>Chemotherapy, Cancer, Regional Perfusion - adverse effects</subject><subject>Chemotherapy, Cancer, Regional Perfusion - methods</subject><subject>DNA - biosynthesis</subject><subject>Fluorouracil - administration & dosage</subject><subject>Fluorouracil - toxicity</subject><subject>Hot Temperature - therapeutic use</subject><subject>Liver - drug effects</subject><subject>Liver - pathology</subject><subject>Male</subject><subject>Rats</subject><subject>Sodium Chloride - adverse effects</subject><subject>Time Factors</subject><issn>0008-543X</issn><issn>1097-0142</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1983</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpVkN1Kw0AQhRdRaq0-grCXepE6-59UEUrUtlAsiIJ3S7bZpStJE5K00rc3obXQqzPDOTNwPoRiAkMCQB8IRCoAwukdiUIGHMi9ICP1RKjgo9F49hLE7_EHDSkIAorwZzaEYbx4pAGcof7x-hz1ASAMBGffl-iqrn_aVVHBeqgnQyqAR300me5KWzUrW-XFcmXzohuT0m4av8R-jbd-W2BfF1nS2BS3UbepfbHGhcNtEldJgzO_tdU1unBJVtubgw7Q19vrZzwN5ovJLB7Pg5ISyQNnlTSWWSGXRppIgeGGWzA0lTRNjaLGKJcyGYm2mmWhVeC4pAk3RnDhDBug2_3fcmNym-qy8nlS7fShUOu7vf_rM7s72gR0h1Z3cHQHR_-j1YJopTu0uiWrT8lqpkHHC007OXHYH03Zc-I</recordid><startdate>19830401</startdate><enddate>19830401</enddate><creator>Miyazaki, Masaru</creator><creator>Makowka, Leonard</creator><creator>Falk, Rudolf E.</creator><creator>Falk, William</creator><creator>Venturi, David</creator><creator>Ambus, Ulo</creator><creator>Falk, Judith A.</creator><general>Wiley Subscription Services, Inc., A Wiley Company</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope></search><sort><creationdate>19830401</creationdate><title>Hyperthermochemotherapeutic in vivo isolated perfusion of the rat liver</title><author>Miyazaki, Masaru ; Makowka, Leonard ; Falk, Rudolf E. ; Falk, William ; Venturi, David ; Ambus, Ulo ; Falk, Judith A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p2164-fe76be3e56cb6b970b4b4e0b2d62ddb72bb7fd3695510e38e70f462a4bb545fb3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1983</creationdate><topic>Alanine Transaminase - blood</topic><topic>Alkaline Phosphatase - blood</topic><topic>Animals</topic><topic>Aspartate Aminotransferases - blood</topic><topic>Bilirubin - blood</topic><topic>Chemotherapy, Cancer, Regional Perfusion - adverse effects</topic><topic>Chemotherapy, Cancer, Regional Perfusion - methods</topic><topic>DNA - biosynthesis</topic><topic>Fluorouracil - administration & dosage</topic><topic>Fluorouracil - toxicity</topic><topic>Hot Temperature - therapeutic use</topic><topic>Liver - drug effects</topic><topic>Liver - pathology</topic><topic>Male</topic><topic>Rats</topic><topic>Sodium Chloride - adverse effects</topic><topic>Time Factors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Miyazaki, Masaru</creatorcontrib><creatorcontrib>Makowka, Leonard</creatorcontrib><creatorcontrib>Falk, Rudolf E.</creatorcontrib><creatorcontrib>Falk, William</creatorcontrib><creatorcontrib>Venturi, David</creatorcontrib><creatorcontrib>Ambus, Ulo</creatorcontrib><creatorcontrib>Falk, Judith A.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><jtitle>Cancer</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Miyazaki, Masaru</au><au>Makowka, Leonard</au><au>Falk, Rudolf E.</au><au>Falk, William</au><au>Venturi, David</au><au>Ambus, Ulo</au><au>Falk, Judith A.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Hyperthermochemotherapeutic in vivo isolated perfusion of the rat liver</atitle><jtitle>Cancer</jtitle><addtitle>Cancer</addtitle><date>1983-04-01</date><risdate>1983</risdate><volume>51</volume><issue>7</issue><spage>1254</spage><epage>1260</epage><pages>1254-1260</pages><issn>0008-543X</issn><eissn>1097-0142</eissn><abstract>This report describes a system of in vivo isolated perfusion of the rat liver. The effects of perfusion with 5‐fluorouracil (5‐FU) (0.125–1.5 g/kg) on survival, liver function, and hepatic regeneration are studied. A dose of 0.125–0.25 g/kg of 5‐FU produced acceptable toxicity with 0% and 25% mortality rate, but induced liver dysfunction indicated by abnormal biochemical values and severe inhibition of hepatic regeneration. Doses of 0.5 g/kg, 1.0 g/kg, and 1.5 g/kg produced a mortality of 60%, 100%, and 100%, respectively. Regional hyperthermia (37–43°C) achieved by perfusion of the liver with heated saline produced an adverse effect on survival, liver function and hepatic regeneration, which are both temperature‐ and perfusion time‐dependent. Hyperthermochemotherapy using in vivo isolated hepatic perfusion might be acceptable for the treatment of unresectable liver cancer, but should not be utilized as an adjuvant therapy prior to hepatic resection without the use of hepatic growth factors which could reverse the inhibitory effect of hepatic perfusion.</abstract><cop>New York</cop><pub>Wiley Subscription Services, Inc., A Wiley Company</pub><pmid>6825049</pmid><doi>10.1002/1097-0142(19830401)51:7<1254::AID-CNCR2820510714>3.0.CO;2-0</doi><tpages>7</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0008-543X |
ispartof | Cancer, 1983-04, Vol.51 (7), p.1254-1260 |
issn | 0008-543X 1097-0142 |
language | eng |
recordid | cdi_pubmed_primary_6825049 |
source | MEDLINE; Alma/SFX Local Collection |
subjects | Alanine Transaminase - blood Alkaline Phosphatase - blood Animals Aspartate Aminotransferases - blood Bilirubin - blood Chemotherapy, Cancer, Regional Perfusion - adverse effects Chemotherapy, Cancer, Regional Perfusion - methods DNA - biosynthesis Fluorouracil - administration & dosage Fluorouracil - toxicity Hot Temperature - therapeutic use Liver - drug effects Liver - pathology Male Rats Sodium Chloride - adverse effects Time Factors |
title | Hyperthermochemotherapeutic in vivo isolated perfusion of the rat liver |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-28T18%3A11%3A19IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-wiley_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Hyperthermochemotherapeutic%20in%20vivo%20isolated%20perfusion%20of%20the%20rat%20liver&rft.jtitle=Cancer&rft.au=Miyazaki,%20Masaru&rft.date=1983-04-01&rft.volume=51&rft.issue=7&rft.spage=1254&rft.epage=1260&rft.pages=1254-1260&rft.issn=0008-543X&rft.eissn=1097-0142&rft_id=info:doi/10.1002/1097-0142(19830401)51:7%3C1254::AID-CNCR2820510714%3E3.0.CO;2-0&rft_dat=%3Cwiley_pubme%3ECNCR2820510714%3C/wiley_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/6825049&rfr_iscdi=true |